The purpose of these directions is to prohibit a person from using a point of care serological (blood) test (including an assay or device) (POC Test) as an acute illness diagnostic tool for COVID-19, as their use may adversely affect the prevention, control and abatement of the serious public health risk present by COVID-19.
Documents
Prohibition on the use of Point of Care Serology Tests Directions